GSK plc (GSK.L)

1.590,00 -20,50 (-1,27%) Börsenschluss: 05:01PM BST

GSK plc

980 Great West Road
Middlesex
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - General
Vollzeitmitarbeiter: 70.212

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Emma Natasha Walmsley	CEO & Director	5,39M	53,92M	1969
Ms. Julie Belita Brown	CFO & Executive Director	5,14M	N/A	1962
Ms. Shobie Ramakrishnan	Chief Digital & Technology Officer	N/A	N/A	1971
Mr. Tony Wood	Chief Scientific Officer and Head of R&D	N/A	N/A	N/A
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A
Mr. James Ford	Senior VP & Group General Counsel of Legal & Compliance	N/A	N/A	N/A
Ms. Sally Jackson	Senior Vice President of Global Communications & CEO Office	N/A	N/A	N/A
Mr. David Simon Redfern BSc (Hons), CA	President of Corporate Development	N/A	N/A	1966
Ms. Diana Conrad	Chief People Officer	N/A	N/A	N/A
Mr. Philip C. Thomson	President of Global Affairs	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate Governance

GSK plcs ISS Governance QualityScore, Stand 1. April 2024, lautet 9. Die grundlegenden Scores sind Audit: 10, Vorstand: 7, Shareholderrechte: 1, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.